Lung Cancer in a Time of COVID-19Medscape Jun 2, 2020
Lung cancer is the leading cause of cancer deaths worldwide, and metastatic non–small cell lung cancer (NSCLC) is the deadliest form, with a 5-year survival rate of just over 5%.
Because lung cancer arises in the lining of the airway, close to the site where oxygen is absorbed into the bloodstream, cancer cells are easily transported to other parts of the body, aiding metastasis.
Nonetheless, thoracic oncologists at the University of Colorado Cancer Center in Aurora who specialize in the treatment of advanced NSCLC say there is room for optimism. In this six-part series, distinguished professor Paul Bunn and his colleagues D. Ross Camidge and Erin Schenk discuss how to choose the optimal treatment for a patient on the basis of pathologic findings, disease staging, and biomarker testing.Read more